Similar articles for PMID: 28057180

Year	Number of Results
1984	1
1988	1
1990	1
1997	1
1999	1
2000	1
2006	1
2012	2
2013	1
2014	13
2015	50
2016	40
2017	25
2018	22
2019	19
2020	10
2021	2
2022	1
2024	0

1

Utilisation des inhibiteurs de PD-1 dans les hémopathies lymphoïdes.

Bounaix L, Bendouda M, Bay JO, Lemal R. Bounaix L, et al. Bull Cancer. 2016 Nov;103 Suppl 1:S160-S163. doi: 10.1016/S0007-4551(16)30374-5. Bull Cancer. 2016. PMID: 28057180 Review. French.

2

Clinical Development of PD-1 Blockade in Hematologic Malignancies.

Pianko MJ, Goldberg AD, Lesokhin AM. Pianko MJ, et al. Cancer J. 2018 Jan/Feb;24(1):31-35. doi: 10.1097/PPO.0000000000000297. Cancer J. 2018. PMID: 29360725 Free PMC article. Review.

3

Checkpoint Inhibition: Programmed Cell Death 1 and Programmed Cell Death 1 Ligand Inhibitors in Hodgkin Lymphoma.

Villasboas JC, Ansell S. Villasboas JC, et al. Cancer J. 2016 Jan-Feb;22(1):17-22. doi: 10.1097/PPO.0000000000000164. Cancer J. 2016. PMID: 26841012 Review.

4

Checkpoint Inhibitors and Other Immune Therapies for Hodgkin and Non-Hodgkin Lymphoma.

Matsuki E, Younes A. Matsuki E, et al. Curr Treat Options Oncol. 2016 Jun;17(6):31. doi: 10.1007/s11864-016-0401-9. Curr Treat Options Oncol. 2016. PMID: 27193488 Free PMC article. Review.

5

Challenges and perspectives in the immunotherapy of Hodgkin lymphoma.

Michot JM, Lazarovici J, Ghez D, Danu A, Fermé C, Bigorgne A, Ribrag V, Marabelle A, Aspeslagh S. Michot JM, et al. Eur J Cancer. 2017 Nov;85:67-77. doi: 10.1016/j.ejca.2017.08.014. Epub 2017 Sep 9. Eur J Cancer. 2017. PMID: 28892775 Review.

6

PD-1 inhibitors effective in hodgkin lymphoma.

[No authors listed] [No authors listed] Cancer Discov. 2015 Feb;5(2):102-3. doi: 10.1158/2159-8290.CD-NB2015-002. Epub 2015 Jan 9. Cancer Discov. 2015. PMID: 25656882 No abstract available.

7

PD-1 Pathway Inhibitors: Immuno-Oncology Agents for Restoring Antitumor Immune Responses.

Medina PJ, Adams VR. Medina PJ, et al. Pharmacotherapy. 2016 Mar;36(3):317-34. doi: 10.1002/phar.1714. Pharmacotherapy. 2016. PMID: 26822752 Free PMC article. Review.

8

PD-1 blockade therapy in renal cell carcinoma: current studies and future promises.

Massari F, Santoni M, Ciccarese C, Santini D, Alfieri S, Martignoni G, Brunelli M, Piva F, Berardi R, Montironi R, Porta C, Cascinu S, Tortora G. Massari F, et al. Cancer Treat Rev. 2015 Feb;41(2):114-21. doi: 10.1016/j.ctrv.2014.12.013. Epub 2015 Jan 6. Cancer Treat Rev. 2015. PMID: 25586601 Review.

9

L’arrivée de l’immunothérapie dans le lymphome de Hodgkin.

Gilardin L, Amorim S, Bernard S, Ravdan O, Thieblemont C, Brice P. Gilardin L, et al. Bull Cancer. 2018 Dec;105 Suppl 1:S50-S58. doi: 10.1016/S0007-4551(18)30390-4. Bull Cancer. 2018. PMID: 30595199 Review. French.

10

Targeting Immune System Alterations in Hodgkin Lymphoma.

Grover NS, Savoldo B. Grover NS, et al. Curr Hematol Malig Rep. 2017 Aug;12(4):358-369. doi: 10.1007/s11899-017-0398-6. Curr Hematol Malig Rep. 2017. PMID: 28780614 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

168 results

Results by year